Genetic Technologies Ltd (GENE)
NASDAQ:GENE
Holding GENE?
Track your performance easily

Genetic Technologies (GENE) Cash flow

474 Followers

Genetic Technologies Cash Flow

GENE's free cash flow for Q4 2024 was AU$―. For the 2024 fiscal year, GENE's free cash flow was decreased by AU$28.63K and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
-AU$ -9.68MAU$ -9.72MAU$ -5.66M--
Investing Cash Flow
AU$ 107.28KAU$ 114.90KAU$ -311.94KAU$ -3.46MAU$ -748.71KAU$ 64.79K
Financing Cash Flow
AU$ -166.48KAU$ 2.82MAU$ 5.92MAU$ -279.06KAU$ 13.69MAU$ 18.36M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
AU$ 16.78MAU$ 1.02MAU$ 7.85MAU$ 11.50MAU$ 20.90MAU$ 14.21M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
----AU$ 15.90MAU$ 21.79M
Issuance Of Debt
-AU$ 2.83MAU$ 6.84MAU$ -268.59KAU$ 0.00AU$ 52.25K
Repayment Of Debt
AU$ -166.48KAU$ -348.91KAU$ -336.40KAU$ -268.59KAU$ -236.89KAU$ -183.91K
Free Cash Flow
AU$ -2.31MAU$ -9.71MAU$ -9.74MAU$ -5.76MAU$ -7.04MAU$ -5.75M
Domestic Sales
------
Foreign Sales
------
Currency in AUD

Genetic Technologies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis